ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00117429
Recruitment Status : Completed
First Posted : July 7, 2005
Last Update Posted : February 15, 2010
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Marcus Altfeld, M.D., Ph.D.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2007
  Actual Study Completion Date : January 2010